Clinical trial
Combination Chemotherapy in Treating Patients With Stage II or Stage III…
NCT00006232 · West of Scotland Lymphoma Group, Other · Completed
Key facts
| NCT number | NCT00006232 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma |
| Official title | A Randomized Trial Comparing Z-Dex With VAD as Induction Therapy for Patients With Multiple Myeloma |
| Lead sponsor | West of Scotland Lymphoma Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Drug |
| Interventions | dexamethasone, doxorubicin hydrochloride, idarubicin, vincristine sulfate |
| Enrollment | 200 |
| Start date | Oct 1, 1996 |
| Completion | Aug 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | May 15, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: